Oppenheimer Asset Management Inc. bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,872 shares of the company’s stock, valued at approximately $582,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Bryn Mawr Trust Advisors LLC purchased a new stake in shares of Corteva in the second quarter valued at approximately $1,938,000. Tema ETFs LLC grew its stake in Corteva by 10.4% in the second quarter. Tema ETFs LLC now owns 10,774 shares of the company’s stock worth $912,000 after purchasing an additional 1,015 shares in the last quarter. City Holding Co. increased its holdings in Corteva by 2.6% during the 2nd quarter. City Holding Co. now owns 25,086 shares of the company’s stock worth $2,124,000 after purchasing an additional 635 shares during the period. Sax Wealth Advisors LLC bought a new stake in Corteva during the 2nd quarter valued at $237,000. Finally, Avity Investment Management Inc. raised its position in Corteva by 14.4% during the 2nd quarter. Avity Investment Management Inc. now owns 5,172 shares of the company’s stock valued at $438,000 after purchasing an additional 650 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. Citigroup increased their price target on Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. Mizuho lifted their price objective on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. CICC Research increased their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Wells Fargo & Company raised their target price on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Finally, Jefferies Financial Group boosted their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average price target of $91.70.
Corteva Stock Performance
Shares of CTVA stock opened at $75.73 on Tuesday. The business’s fifty day simple moving average is $81.78 and its 200-day simple moving average is $80.09. The company has a market cap of $50.53 billion, a PE ratio of 50.15, a PEG ratio of 2.35 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the firm earned $2.20 EPS. The business’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also
- Five stocks we like better than Corteva
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
